Polycistronic lentivirus induced pluripotent stem cells from skin biopsies after long term storage, blood outgrowth endothelial cells and cells from milk teeth

Differentiation

Volumn 85, Issue 3, 2013, Pages 101-109

  Dambrot, C ^a   van de Pas, S ^a   van Zijl, L ^a   Brandl B ^b   Wang, J W ^a,c   Schalij, M J ^a   Hoeben, R C ^a   Atsma, D E ^a   Mikkers, H M ^a   Mummery, C L ^a   Freund, C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Blood outgrowth endothelial cells; Human induced pluripotent stem cell; Milk teeth; Tissue storage

Indexed keywords

CELL MARKER; LENTIVIRUS VECTOR;

ARTICLE; BLOOD OUTGROWTH ENDOTHELIUM CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL INVASION; CELL ISOLATION; CELL LINE; CELL STORAGE; CELL TRANSPORT; CHILD; CONTROLLED STUDY; DECIDUOUS TOOTH; ECTODERM; EMBRYONIC STEM CELL; ENDODERM; ENDOTHELIUM CELL; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; LENTIVIRINAE; MALE; MESODERM; MINIMALLY INVASIVE PROCEDURE; NON INVASIVE PROCEDURE; NORMAL HUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRESERVATION AND STORAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; SCHOOL CHILD; SIGNAL TRANSDUCTION; SKIN BIOPSY; SKIN FIBROBLAST; SOMATIC CELL; TISSUE PRESERVATION; TOOTH PULP; TRANSGENE;

BIOPSY; BLOOD CELLS; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; GENES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LENTIVIRUS; SKIN; SODIUM CHLORIDE; TOOTH, DECIDUOUS;

EID: 84877330336     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2013.01.001     Document Type: Article

References (30)

1. Banito A., Gil J. Induced pluripotent stem cells and senescence: learning the biology to improve the technology. EMBO Reports 2010, 11:353-359.
2. Carlotti F., Bazuine M., Kekarainen T., Seppen J., Pognonec P., Maassen J.A., Hoeben R.C. Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes. Molecular Therapy 2004, 9:209-217.
3. Chan E.M., Ratanasirintrawoot S., Park I.H., Manos P.D., Loh Y.H., Huo H., Miller J.D., Hartung O., Rho J., Ince T.A., Daley G.Q., Schlaeger T.M. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nature Biotechnology 2009, 27:1033-1037.
4. Dambrot C., Passier R., Atsma D., Mummery C.L. Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models. Biochemical Journal 2011, 434:25-35.
5. Davis R.P., van den Berg C.W., Casini S., Braam S.R., Mummery C.L. Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development. Trends in Molecular Medicine 2011, 17:475-484.
6. Elliott D.A., Braam S.R., Koutsis K., Ng E.S., Jenny R., Lagerqvist E.L., Biben C., Hatzistavrou T., Hirst C.E., Yu Q.C., Skelton R.J., Ward-van O.D., Lim S.M., Khammy O., Li X., Hawes S.M., Davis R.P., Goulburn A.L., Passier R., Prall O.W., Haynes J.M., Pouton C.W., Kaye D.M., Mummery C.L., Elefanty A.G., Stanley E.G. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nature Methods 2011, 8:1037-1040.
7. Eminli S., Foudi A., Stadtfeld M., Maherali N., Ahfeldt T., Mostoslavsky G., Hock H., Hochedlinger K. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nature Genetics 2009, 41:968-976.
8. Esteban M.A., Wang T., Qin B., Yang J., Qin D., Cai J., Li W., Weng Z., Chen J., Ni S., Chen K., Li Y., Liu X., Xu J., Zhang S., Li F., He W., Labuda K., Song Y., Peterbauer A., Wolbank S., Redl H., Zhong M., Cai D., Zeng L., Pei D. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 2010, 6:71-79.
9. Freund C., Mummery C.L. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models. Journal of Cellular Biochemistry 2009, 107:592-599.
10. Geti I., Ormiston M.L., Rouhani F., Toshner M., Movassagh M., Nichols J., Mansfield W., Southwood M., Bradley A., Rana A.A., Vallier L., Morrell N.W. A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: blood-derived endothelial progenitor cells. Stem Cells Translational Medicine 2012, 1:855-865.
11. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Experimental Cell Research 1961, 25:585-621.
12. Kim K., Zhao R., Doi A., Ng K., Unternaehrer J., Cahan P., Huo H., Loh Y.H., Aryee M.J., Lensch M.W., Li H., Collins J.J., Feinberg A.P., Daley G.Q. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nature Biotechnology 2011, 29:1117-1119.
13. Kolbe M., Dohle E., Katerla D., Kirkpatrick C.J., Fuchs S. Enrichment of outgrowth endothelial cells in high and low colony-forming cultures from peripheral blood progenitors. Tissue Engineering Part C: Methods 2010, 16:877-886.
14. Liew A., Barry F., O'Brien T. Endothelial progenitor cells: diagnostic and therapeutic considerations. Bioessays 2006, 28:261-270.
15. Loh Y.H., Hartung O., Li H., Guo C., Sahalie J.M., Manos P.D., Urbach A., Heffner G.C., Grskovic M., Vigneault F., Lensch M.W., Park I.H., Agarwal S., Church G.M., Collins J.J., Irion S., Daley G.Q. Reprogramming of T cells from human peripheral blood. Cell Stem Cell 2010, 7:15-19.
16. Luong M.X., Auerbach J., Crook J.M., Daheron L., Hei D., Lomax G., Loring J.F., Ludwig T., Schlaeger T.M., Smith K.P., Stacey G., Xu R.H., Zeng F. A call for standardized naming and reporting of human ESC and iPSC lines. Cell Stem Cell 2011, 8:357-359.
17. Mikkelsen T.S., Hanna J., Zhang X., Ku M., Wernig M., Schorderet P., Bernstein B.E., Jaenisch R., Lander E.S., Meissner A. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008, 454:49-55.
18. Müller F.J., Schuldt B.M., Williams R., Mason D., Altun G., Papapetrou E.P., Danner S., Goldmann J.E., Herbst A., Schmidt N.O., Aldenhoff J.B., Laurent L.C., Loring J.F. A bioinformatic assay for pluripotency in human cells. Nature Methods 2011, 8:315-317.
19. Ohnuki M., Takahashi K., Yamanaka S. Generation and characterization of human induced pluripotent stem cells. Current Protocols in Stem Cell Biology 2009, (Chapter 4 Unit).
20. Reinisch A., Hofmann N.A., Obenauf A.C., Kashofer K., Rohde E., Schallmoser K., Flicker K., Lanzer G., Linkesch W., Speicher M.R., Strunk D. Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood 2009, 113:6716-6725.
21. Sridharan R., Tchieu J., Mason M.J., Yachechko R., Kuoy E., Horvath S., Zhou Q., Plath K. Role of the murine reprogramming factors in the induction of pluripotency. Cell 2009, 136:364-377.
22. Stadtfeld M., Brennand K., Hochedlinger K. Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Current Biology 2008, 18:890-894.
23. Stadtfeld M., Nagaya M., Utikal J., Weir G., Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008, 322:945-949.
24. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
25. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
26. Tamaoki N., Takahashi K., Tanaka T., Ichisaka T., Aoki H., Takeda-Kawaguchi T., Iida K., Kunisada T., Shibata T., Yamanaka S., Tezuka K. Dental pulp cells for induced pluripotent stem cell banking. Journal of Dental Research 2010, 89:773-778.
27. Tiscornia G., Vivas E.L., Belmonte J.C. Diseases in a dish: modeling human genetic disorders using induced pluripotent cells. Nature Medicine 2011, 17:1570-1576.
28. Warlich E., Kuehle J., Cantz T., Brugman M.H., Maetzig T., Galla M., Filipczyk A.A., Halle S., Klump H., Scholer H.R., Baum C., Schroeder T., Schambach A. Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. Molecular Therapy 2011, 19:782-789.
29. Wang, J.W., Bouwens, E.A.M., Pintao, M.C., Voorberg, J., Valentijn, K.M., de Boer, H.C., Reitsma, P.H., Eikenboom, J., Analysis of storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from von Willebrand disease patients. Submitted for publication.
30. Yamanaka S. Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 2012, 10:678-684.